Search results for "Ovulation Induction"

showing 10 items of 54 documents

PCOS and infertility. Metformin administration and ovulation induction in patients with reproductive failures. Preliminary data

2014

The aim of this study is to investigate the effects of the metformin administration in patients with previous reproductive failures. Inclusion criteria: 13 patients with chronic anovulation and PCOS, age < 38 years old, sterility not less than 2 years, C.C. resistance, conception failure in previous cycles with only r-FSH and negativity to the multiple miscarriages tests, absence of others infertility factors. Metformin administration started 2 months before the ovulation induction. Alternatively a spontaneous menstruation it was induced by progestin. Ovulation was performed with r-FSH and patients were invited to have sexual intercourse during the 48h after the HCG trigger. Luteal support …

InfertilityGynecologymedicine.medical_specialtybusiness.industrymedicine.medical_treatmentPCOS InfertilityMetforminOvulation inductionPregnancy.medicine.diseaseSettore MED/40 - Ginecologia E OstetriciaMetforminmedicineOvulation inductionIn patientbusinessAdministration (government)medicine.drugGiornale Italiano di Ostetricia e Ginecologia
researchProduct

Clinical management of endometrial receptivity.

2014

The endometrial window of implantation (WOI), the cycle days during which normal embryo implantation can occur, has generally been assumed to begin on cycle day 19 or 20 of an idealized 28 days cycle and last for 4 to 5 days. Noyes et al took the first steps in defining the WOI by establishing a set of morphological criteria to evaluate endometrial development and receptivity, but recent studies have invalidated their use in the routine evaluation of infertility. Based on greater than 10 years of extensive research, our group has developed a molecular diagnostic tool (the endometrial receptivity array [ERA] test) based on the specific transcriptomic signature that identifies the receptive e…

Infertilitymedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentReceptivityEndometriumEndometriumEndocrinologyOvulation InductionPhysiology (medical)MedicineHumansIn patientEmbryo ImplantationPrecision MedicineGynecologybusiness.industryHormonal replacement therapyObstetrics and Gynecologymedicine.diseaseEmbryo TransferEmbryo transfermedicine.anatomical_structureReproductive MedicineOvulation inductionFemaleEndometrial receptivitybusinessInfertility FemaleSeminars in reproductive medicine
researchProduct

Ovulation induction and epigenetic anomalies

2013

In this systematic review of ovulation induction and epigenetic control, studies mainly done in the mouse model highlight how hormone treatments may be prejudicial to the epigenetic reprogramming of gametes as well as early embryos. Moreover, the hormone protocols used in assisted reproduction may also modify the physiologic environment of the uterus, a potential link to endometrial epigenetic disturbances. At present, the few available data in humans are insufficient to allow us to independently determine the impact of a woman's age and infertility problems and treatment protocols and hormone doses on such processes as genomic imprinting.

Infertilitymedicine.medical_specialtyReproductive Techniques Assistedmedicine.medical_treatmentBiologyBioinformaticsEpigenesis GeneticMiceOvulation InductionInternal medicinemedicineAnimalsHumansEpigeneticsEpigenesisGenetic Diseases InbornObstetrics and Gynecologymedicine.diseaseEndocrinologyReproductive MedicineModels AnimalDNA methylationFemaleOvulation inductionGenomic imprintingReprogrammingHormoneFertility and Sterility
researchProduct

Ovarian stimulation for ovulation induction and in vitro fertilization in patients with systemic lupus erythematosus and antiphospholipid syndrome.

2008

Objective To review the current evidence regarding the relationship between systemic lupus erythematosus (SLE) and antiphospholipid syndrome and female infertility, as well as the risks associated with ovarian stimulation for ovulation induction and IVF. To establish, based on this information, guidelines for safe and successful assisted reproductive technology (ART). Design A MEDLINE computer search was performed to identify relevant articles. Result(s) Systemic lupus erythematosus and antiphospholipid syndrome are not related to infertility, except for cases of amenorrhea accompanying severe flares, renal insufficiency-related hypofertility, and ovarian failure secondary to cyclophosphami…

Infertilitymedicine.medical_specialtymedicine.medical_treatmentOvarian hyperstimulation syndromeFertilization in VitroOvulation Inductionimmune system diseasesAntiphospholipid syndromePregnancyRisk FactorsmedicineHumansLupus Erythematosus Systemicskin and connective tissue diseasesIn vitro fertilisationLupus erythematosusSystemic lupus erythematosusbusiness.industryObstetricsFemale infertilityObstetrics and Gynecologymedicine.diseaseAntiphospholipid SyndromeReproductive MedicineImmunologyOvulation inductionFemalebusinessInfertility FemaleFertility and sterility
researchProduct

Gamete intrafallopian transfer in the treatment of infertility: the first series at the University of Palermo

1986

Twenty-six couples with unexplained infertility (UI), nine women with repeated failures of artificial insemination with donor semen (AID), three women with mild endometriosis, three with periadnexal adhesions, one with hostile (not immunologic) cervical mucus, and one couple in which the male partner was affected by asthenospermia were treated by the gamete intrafallopian transfer (GIFT) technique. Three different protocols for controlled ovarian hyperstimulation were used, and an adequate follicular growth and oocyte maturation were achieved in all cases. Seventeen pregnancies were obtained, for a global pregnancy rate of 38.6%. Two pregnancies (11.7%) ended in clinical abortions, and one …

MaleInfertilitymedicine.medical_specialtyMenotropinsmedicine.medical_treatmentEndometriosisControlled ovarian hyperstimulationChorionic GonadotropinClomipheneOvulation InductionmedicineHumansGamete intrafallopian transferFallopian TubesInsemination ArtificialUnexplained infertilityGynecologyClinical Trials as TopicPregnancyObstetricsbusiness.industryArtificial inseminationObstetrics and GynecologyMiddle Agedmedicine.diseaseSpermatozoaPregnancy rateReproductive MedicineInfertilityOocytesFemalebusinessFertility and Sterility
researchProduct

The impact of ovarian stimulation on the expression of candidate reprogramming genes in mouse preimplantation embryos.

2012

Ovarian stimulation with gonadotrophins is an integral part of assisted reproductive technologies in human subfertility/infertility treatment. Recent findings have associated ovarian stimulation with the increased incidence of imprinting disorders in humans as well as defects in genome-wide methylation reprogramming and, in particular, imprinting in mice. Here, we present the first study that determined the impact of ovarian stimulation on the expression of developmentally important reprogramming genes &lt;i&gt;(Apex1, Lig1, Lig3, Mbd2, Mbd3, Mbd4, &lt;/i&gt;and&lt;i&gt; Polb)&lt;/i&gt; in single early mouse morula embryos (16-cell stage). Using absolute quantification of mRNA by quantitati…

Malemedicine.medical_specialtyTime FactorsGonadotropins EquineDown-RegulationStimulationReproductive technologyBiologyChorionic GonadotropinMBD4AndrologyMiceOogenesisOvulation InductionInternal medicineGeneticsmedicineDNA-(Apurinic or Apyrimidinic Site) LyaseAnimalsHumansHorsesRNA MessengerMolecular BiologyGenetics (clinical)GametogenesisDNA Polymerase betaRegulation of gene expressionReverse Transcriptase Polymerase Chain ReactionEmbryogenesisGene Expression Regulation DevelopmentalEmbryoDNA-Binding ProteinsMice Inbred C57BLEndocrinologyBlastocystMicroscopy Fluorescenceembryonic structuresFemaleReprogrammingTranscription FactorsCytogenetic and genome research
researchProduct

The significance of premature luteinization in an oocyte-donation programme

2006

BACKGROUND: Several evidences indicate that premature luteinization (PL) may affect IVF outcome. The primary end-point of the present study was to verify the effect of PL on the pregnancy rate (PR) of our oocytedonation programme. METHODS: PL was defined as serum progesterone ³1.2 ng/ml on the day of HCG. We analysed retrospectively 240 oocyte-donation cycles in which 120 women donated twice, with PL in the first donation cycle and no PL in the following one, acting as its own control. Recipients (n = 240) were divided in two groups according to the presence of PL (n = 120) or not (n = 120). Both groups were compared regarding donor cycle parameters and recipient cycle outcome. RESULTS: The…

Malemedicine.medical_specialtymedicine.medical_treatmentFertilization in VitroBiologyGonadotropin-Releasing HormoneAndrologyHuman fertilizationOvulation InductionPregnancymedicineHumansBlastocystProgesteroneRetrospective StudiesGynecologyPregnancyOocyte DonationRehabilitationEmbryo donationObstetrics and GynecologyEmbryo TransferOocytemedicine.diseaseEmbryo transferLuteinizationPregnancy rateBlastocystTreatment Outcomemedicine.anatomical_structureReproductive MedicineOocytesFemaleOvulation inductionHuman Reproduction
researchProduct

Ovulation-inducing activity of luliberin (LHRH) complexed by copper(II), nickel(II), and zinc(II) ions.

1990

We have shown that the complexation of luteinizing hormone releasing hormone, luliberin (LHRH), a hypothalamic neurohormone, by Cu(II), Ni(II), and Zn(II) may affect its basic, ovulation-inducing potency in the dose responsive manner. Some explanation of the obtained results are offered here.

Ovulationendocrine systemmedicine.medical_specialtymedia_common.quotation_subjectMolecular Sequence Datachemistry.chemical_elementZincGonadotropin-releasing hormonePeptide hormoneBiochemistryInorganic ChemistryMetalGonadotropin-Releasing HormoneOvulation InductionNickelInternal medicinemedicineAnimalsAmino Acid SequenceRats Inbred BUFOvulationmedia_commonRats Inbred StrainsCopperRatsZincEndocrinologychemistryvisual_artvisual_art.visual_art_mediumFemaleLuteinizing hormoneCopperNuclear chemistryHormoneJournal of inorganic biochemistry
researchProduct

The type of GnRH analogue used during controlled ovarian stimulation influences early embryo developmental kinetics: a time-lapse study

2013

OBJECTIVE: To explore if the GnRH analogue used for controlled ovarian stimulation (COS) and the ovulation triggering factor (GnRH agonist + hCG triggering versus GnRH antagonist + GnRH agonist triggering) affect embryo development and kinetics.STUDY DESIGN: In a retrospective cohort study in the Instituto Valenciano de Infertilidad (IVI) Alicante and the Instituto Universitario-IVI Valencia, Spain, 2817 embryos deriving from 400 couples undergoing oocyte donation were analysed. After controlled ovarian stimulation and IVF/intracytoplamic sperm injection, the timing of embryonic cleavages was assessed by a video time-lapse system. The results were analysed using Student's t test for compari…

Pregnancy RateZygoteGonadotropin-Releasing Hormone/adverse effectsmedicine.medical_treatmentGonadotropin-releasing hormoneChorionic GonadotropinGonadotropin-Releasing HormoneEmbryo Culture TechniquesCohort StudiesTime-lapsePregnancyGnRH analogueFertility Agents Female/adverse effectsmedia_commonOocyte DonationObstetrics and GynecologyEmbryoEmbryo transferembryonic structuresSpain/epidemiologyEctogenesis/drug effectsFemaleInfertility Femalehormones hormone substitutes and hormone antagonistsEmbryo qualityAdultAgonistInfertility Female/therapyendocrine systemmedicine.medical_specialtymedicine.drug_classCleavage Stage Ovummedia_common.quotation_subjectFertilization in VitroBiologyTime-Lapse ImagingOvulation InductionInternal medicinemedicineHumansOvulationRetrospective StudiesZygote/drug effectsFertility Agents FemaleOvulation Induction/methodsEmbryo TransferEmbryo developmental kineticsKineticsPregnancy rateEndocrinologyReproductive MedicineSpainEctogenesisChorionic Gonadotropin/pharmacologyOvulation inductionCleavage Stage Ovum/drug effectsEuropean Journal of Obstetrics &amp; Gynecology and Reproductive Biology
researchProduct

Physiology and Pathology of Ovarian Hyperstimulation Syndrome

2010

Ovarian hyperstimulation syndrome (OHSS) occurs when ovaries primed with follicle-stimulating hormone/leuteinizing hormone (LH) are subsequently exposed to human chorionic gonadotropin (hCG). The ultimate pathophysiological step underlying this clinical picture is increased vascular permeability (VP). With the administration of hCG, the expression vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR-2) mRNA increases significantly rising to a maximum coinciding with peaked VP. Immunohistochemistry shows the presence of VEGF and VEGFR-2 proteins in the granulosa-lutein and endothelial cells of the entire corpus luteum. These findings suggest that the syndrome can be prevented…

Vascular Endothelial Growth Factor AAgonistendocrine systemmedicine.medical_specialtymedicine.drug_classEndocrinology Diabetes and MetabolismOvarian hyperstimulation syndromeBiologyModels BiologicalDopamine agonistHuman chorionic gonadotropinOvarian Hyperstimulation SyndromeEndocrinologyOvulation InductionPregnancyPhysiology (medical)Internal medicineCabergolinemedicineAnimalsHumansLeuteinizing hormoneQuinagolideObstetrics and GynecologyFertility Agents Femalemedicine.diseaseVascular Endothelial Growth Factor Receptor-2medicine.anatomical_structureEndocrinologyReproductive MedicineDopamine AgonistsFemaleCorpus luteummedicine.drugSeminars in Reproductive Medicine
researchProduct